Terumo Corporation: Business Overview, Financials & Competitive Analysis
Terumo Corporation scores 7/10 on the AskCyborg Cyborg Score (Solid). Established global medical device leader with proven innovation capability and favorable demographic tailwinds, trading on solid fundamentals with modest growth prospects. Terumo demonstrates strong fundamentals with diversified medical device portfolio, consistent revenue growth, and strategic positioning in high-demand markets. However, pricing pressures and competitive consolidation in the industry present ongoing.
What is Terumo Corporation's industry? Terumo Corporation (terumo.com) operates in Medical Devices & Healthcare Technology. AskCyborg classifies Terumo Corporation under Medical Devices & Healthcare Technology in its company registry.
Terumo is a global leader in medical technology with over 100 years of heritage in healthcare innovation. The company produces prefilled syringes, insulin patch pumps, neurovascular and cardiac vascular interventional...
Cyborg Score thesis
Established global medical device leader with proven innovation capability and favorable demographic tailwinds, trading on solid...
Read the full analyst-debate transcript →Get the Latest Terumo Corporation Report
Up-to-date AI-powered research, analyst debate audio & saved-company playlists
Get Current Report FreeTerumo Corporation Overview
Pro stress-test →Terumo is a global leader in medical technology with over 100 years of heritage in healthcare innovation. The company produces prefilled syringes, insulin patch pumps, neurovascular and cardiac vascular interventional devices, and blood processing systems, with cardiac and vascular business contributing over 60% of total revenue. North America represents 38% of Terumo's revenue, establishing it as a truly global player.
Strategic Profile
Pro stress-test →Strong product innovation, market share gains, and demographic trends position the company for sustained expansion, while operational improvements and strategic R&D investments support long-term margin growth. Growing demand in major markets and effective pricing increases in cardiovascular segments, combined with expansion in China and high-margin consumables, are boosting profitability and cash flow.
Competitive Landscape
Pro stress-test →Primary competitors include Boston Scientific, Medtronic, and Merit Medical Systems, alongside regional players like Japan Lifeline and Asahi Intecc. Terumo competes through product innovation, manufacturing excellence, and market share gains in high-margin therapeutic segments.
Industry Context
Terumo Corporation operates in Medical Devices & Healthcare Technology.
Key facts
Founded: 1921 · Headquarters: Tokyo, Japan · Employees: 30,000+ · Revenue: 1.04 trillion JPY (2024)